Posted August 16, 2019
A study published in the journal PLoS Medicine brings to light some alarming facts about the business model of the most prestigious medical journals which leaves them reliant on Big Pharma funding—an obvious conflict of interest for publications that are supposed to be sources of unbiased information about drugs and medical treatments.  Read more.